v3.26.1
Business Segment Information (Tables)
 9 Months Ended
Jul. 31, 2026
Segment Reporting [Abstract]  
Schedule of Business Segment Net Sales
Segment information:
Periods Ended July 31,Three MonthsNine Months
(In millions)2026202520262025
CooperVision net sales by category:
Toric and multifocal$363.8 $358.8 $1,079.9 $1,006.6 
Sphere, other353.2 359.6 1,055.7 1,027.5 
Total CooperVision net sales$717.0 $718.4 $2,135.6 $2,034.1 
CooperSurgical net sales by category:
Office and surgical$208.0 $204.8 $624.6 $609.5 
Fertility141.2 137.1 411.6 383.7 
Total CooperSurgical net sales349.2 341.9 1,036.2 993.2 
Total net sales$1,066.2 $1,060.3 $3,171.8 $3,027.3 
Schedule of Business Segment Information
(In millions)CooperVisionCooperSurgical
Corporate (1)
Consolidated
Three Months Ended July 31, 2026
Net sales$717.0 $349.2 $— $1,066.2 
Cost of sales240.4 113.9 — 354.3 
Selling, general and administrative expense244.6 132.1 24.6 401.3 
Research and development expense22.3 19.3 — 41.6 
Amortization of intangibles4.2 42.8 — 47.0 
Operating income (loss)$205.5 $41.1 $(24.6)$222.0 
Interest expense21.5 
Other (income) expense, net
(1.3)
Income before income taxes
$201.8 
Depreciation expense$40.9 $6.7 $— $47.6 
Capital expenditures$60.4 $8.3 $— $68.7 
As of July 31, 2026
Identifiable assets$7,915.1 $4,542.7 $215.6 $12,673.4 
Three Months Ended July 31, 2025
Net sales$718.4 $341.9 $— $1,060.3 
Cost of sales238.3 130.0 — 368.3 
Selling, general and administrative expense248.1 150.9 22.7 421.7 
Research and development expense24.3 20.3 — 44.6 
Amortization of intangibles5.1 44.9 — 50.0 
Operating income (loss)$202.6 $(4.2)$(22.7)$175.7 
Interest expense25.4 
Other (income) expense, net(1.6)
Income before income taxes$151.9 
Depreciation expense$39.0 $6.7 $— $45.7 
Capital expenditures$86.4 $10.5 $— $96.9 
As of October 31, 2025
Identifiable assets$7,604.4 $4,619.3 $171.1 $12,394.8 
(1) Corporate selling, general and administrative (SGA) expense is not allocated to the segments.
(In millions)CooperVisionCooperSurgical
Corporate (1)
Consolidated
Nine Months Ended July 31, 2026
Net sales$2,135.6 $1,036.2 $— $3,171.8 
Cost of sales690.6 338.7 — 1,029.3 
Selling, general and administrative expense734.4 662.9 70.4 1,467.7 
Research and development expense66.8 61.6 — 128.4 
Amortization of intangibles12.5 130.1 — 142.6 
Operating income (loss)$631.3 $(157.1)$(70.4)$403.8 
Interest expense64.8 
Other (income) expense, net
(6.6)
Income before income taxes
$345.6 
Depreciation expense$123.3 $19.7 $— $143.0 
Capital expenditures$231.2 $26.1 $— $257.3 
Nine Months Ended July 31, 2025
Net sales$2,034.1 $993.2 $— $3,027.3 
Cost of sales658.9 337.1 — 996.0 
Selling, general and administrative expense714.9 423.6 70.1 1,208.6 
Research and development expense72.4 58.4 — 130.8 
Amortization of intangibles15.0 134.4 — 149.4 
Operating income (loss)$572.9 $39.7 $(70.1)$542.5 
Interest expense75.6 
Other (income) expense, net
17.2 
Income before income taxes$449.7 
Depreciation expense$111.4 $18.7 $— $130.1 
Capital expenditures$231.4 $33.0 $— $264.4 
(1) Corporate SGA expense is not allocated to the segments.
Schedule of Net Sales to Unaffiliated Customers by Country of Domicile
Geographic information:
Periods Ended July 31,Three MonthsNine Months
(In millions)2026202520262025
Net sales to unaffiliated customers by country of domicile:
United States$519.5 $516.2 $1,581.2 $1,527.8 
Europe357.5 343.1 1,025.5 922.5 
Rest of world189.2 201.0 565.1 577.0 
Total$1,066.2 $1,060.3 $3,171.8 $3,027.3 
Schedule of Net Property, Plant and Equipment by Country of Domicile
(In millions)July 31, 2026October 31, 2025
Net property, plant and equipment by country of domicile:
United States$1,439.1 $1,389.4 
Europe452.6 429.1 
Rest of world253.2 263.5 
Total$2,144.9 $2,082.0